Blagden S - Search Results

1

First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer.

Blagden S, Omlin A, Josephs D, Stavraka C, Zivi A, Pinato DJ, Anthoney A, Decordova S, Swales K, Riisnaes R, Pope L, Noguchi K, Shiokawa R, Inatani M, Prince J, Jones K, Twelves C, Spicer J, Banerji U. Blagden S, et al. Clin Cancer Res. 2014 Dec 1;20(23):5908-17. doi: 10.1158/1078-0432.CCR-14-1315. Epub 2014 Sep 17. Clin Cancer Res. 2014. PMID: 25231405 Free PMC article. Clinical Trial.

2

A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours.

Attard G, Kitzen J, Blagden SP, Fong PC, Pronk LC, Zhi J, Zugmaier G, Verweij J, de Bono JS, de Jonge M. Attard G, et al. Among authors: blagden sp. Br J Cancer. 2007 Nov 19;97(10):1338-43. doi: 10.1038/sj.bjc.6604043. Epub 2007 Nov 13. Br J Cancer. 2007. PMID: 18000498 Free PMC article. Clinical Trial.

3

Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer.

Sharma R, Graham J, Mitchell H, Brooks A, Blagden S, Gabra H. Sharma R, et al. Among authors: blagden s. Br J Cancer. 2009 Mar 10;100(5):707-12. doi: 10.1038/sj.bjc.6604914. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223898 Free PMC article.

4

Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies.

Olmos D, Barker D, Sharma R, Brunetto AT, Yap TA, Taegtmeyer AB, Barriuso J, Medani H, Degenhardt YY, Allred AJ, Smith DA, Murray SC, Lampkin TA, Dar MM, Wilson R, de Bono JS, Blagden SP. Olmos D, et al. Among authors: blagden sp. Clin Cancer Res. 2011 May 15;17(10):3420-30. doi: 10.1158/1078-0432.CCR-10-2946. Epub 2011 Apr 1. Clin Cancer Res. 2011. PMID: 21459796 Clinical Trial.

5

A study of symptoms described by ovarian cancer survivors.

Stavraka C, Ford A, Ghaem-Maghami S, Crook T, Agarwal R, Gabra H, Blagden S. Stavraka C, et al. Among authors: blagden s. Gynecol Oncol. 2012 Apr;125(1):59-64. doi: 10.1016/j.ygyno.2011.12.421. Epub 2011 Dec 9. Gynecol Oncol. 2012. PMID: 22155797

6

A study to evaluate the cause of bone demineralization in gynecological cancer survivors.

Stavraka C, Maclaran K, Gabra H, Agarwal R, Ghaem-Maghami S, Taylor A, Dhillo WS, Panay N, Blagden SP. Stavraka C, et al. Among authors: blagden sp. Oncologist. 2013;18(4):423-9. doi: 10.1634/theoncologist.2012-0416. Epub 2013 Jan 30. Oncologist. 2013. PMID: 23363808 Free PMC article.

7

Developing an objective marker to optimize patient selection and predict survival benefit in early-phase cancer trials.

Stavraka C, Pinato DJ, Turnbull SJ, Flynn MJ, Forster MD, O'Cathail SM, Babar S, Seckl MJ, Kristeleit RS, Blagden SP. Stavraka C, et al. Among authors: blagden sp. Cancer. 2014 Jan 15;120(2):262-70. doi: 10.1002/cncr.28381. Epub 2013 Oct 8. Cancer. 2014. PMID: 24399418 Free article.

8

An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials.

Pinato DJ, Stavraka C, Flynn MJ, Forster MD, O'Cathail SM, Seckl MJ, Kristeleit RS, Olmos D, Turnbull SJ, Blagden SP. Pinato DJ, et al. Among authors: blagden sp. PLoS One. 2014 Jan 7;9(1):e83279. doi: 10.1371/journal.pone.0083279. eCollection 2014. PLoS One. 2014. PMID: 24409281 Free PMC article.

9

Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation.

Hopkins TG, Stavraka C, Gabra H, Fallowfield L, Hood C, Blagden S. Hopkins TG, et al. Among authors: blagden s. Climacteric. 2015 Feb;18(1):94-8. doi: 10.3109/13697137.2014.929104. Epub 2014 Jul 16. Climacteric. 2015. PMID: 25029389

10

Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.

Rizzuto I, Stavraka C, Chatterjee J, Borley J, Hopkins TG, Gabra H, Ghaem-Maghami S, Huson L, Blagden SP. Rizzuto I, et al. Among authors: blagden sp. Int J Gynecol Cancer. 2015 Mar;25(3):416-22. doi: 10.1097/IGC.0000000000000361. Int J Gynecol Cancer. 2015. PMID: 25647256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters